Background: It remains controversial whether cardiac strain accurately predicts adverse events after acute ST-segment elevation myocardial infarction (STEMI). The aim of the present study was to evaluate the effects of cardiac strain revealed on cardiac magnetic resonance (CMR) imaging on cardiac events and adverse left ventricular (LV) remodeling.Methods: Between February 2015 and September 2016, we conducted a prospective two-center cohort study of patients with STEMI treated with primary percutaneous coronary intervention comprising stent implantation. All included patients underwent CMR imaging before discharge. Major adverse cardiac events (MACE) and LV remodeling were assessed during 6 months of follow-up.Results: Seventy-six patients were available for the final analysis. The MACE rate was 23.7%, using cardiac death, reinfarction, unplanned revascularization, and heart failure as combined events during 6 months of follow-up. The global longitudinal strain (GLS) was an independent predictor of MACE (OR=1.21 (1.07–1.36), P=0.002) and LV remodeling (OR=2.06 (1.14–3.73), P=0.017).Conclusion: In patients with STEMI treated with primary percutaneous coronary intervention, the GLS determined on CMR imaging performed before discharge is a predictor of MACE and adverse LV remodeling during 6 months of follow-up.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.